Hopp til hovedinnhold

Urinretensjon, akutt

Sist revidert:
Sist revidert av:

  1. Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018 Oct 15;98(8):496-503. PubMed  
  2. Rosenstein D, McAninch JW. Urologic emergencies. Med Clin North Am 2004; 88: 495-518. PubMed  
  3. Fitzpatrick JM, Desgrandchamps F, Adjali K, et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int 2012; 109: 88-95. pmid:22117624 PubMed  
  4. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. pmid:11857671 PubMed  
  5. Negro CL, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int 2012; 110: 1590-4. pmid:22452619 PubMed  
  6. Cathcart P, van der Meulen J, Armitage J, Emberton M. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England. J Urol 2006; 176: 200-4. pmid:16753401 PubMed  
  7. Roehrborn CG. Acute urinary retention: risks and management. Rev Urol 2005; 7(suppl 4): 31-41.
  8. Emberton M, Fitzpatrick JM. The Reten-World survey of the management of acute urinary retention: preliminary results. BJU Int 2008; 101: Suppl 3:27-32. pmid:18307683 PubMed  
  9. Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urol Clin North Am 2003; 30: 1-12. pmid:12580554 PubMed  
  10. Afonso AS, Verhamme KM, Stricker BH, et al. Inhaled anticholinergic drugs and risk of acute urinary retention. BJU Int 2011; 107: 1265-72. pmid:20880196 PubMed  
  11. Armitage JN, Sibanda N, Cathcart PJ, et al. Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ 2007; 335: 1199-202. pmid:17991937 PubMed  
  12. Lam TBL, Omar MI, Fisher E, Gillies K, MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No.: CD004013.
  13. McPhail MJ, Abu-Hilal M, Johnson CD. A meta-analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery. Br J Surg 2006; 93: 1038-44. pmid:16804872 PubMed  
  14. Emberton M, Fitzpatrick JM, Rees J. Risk stratification for benign prostatic hyperplasia (BPH) treatment. BJU Int 2011; 107: 876-80. pmid:21265993 PubMed  
  15. Teoh JY, Kan CF, Tsui B, et al. Ambulatory care program for patients presenting with acute urinary retention secondary to benign prostatic hyperplasia. Int Urol Nephrol 2012; 44: 1593-9. pmid:22914880 PubMed  
  16. Emberton M, Cornel EB, Bassi PF, et al. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract 2008; 62: 1076-86. pmid: 18479366 PubMed  
  17. Roehrborn CG, Bruskewitz R, Nickel JC, et al. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia. J Urol 2004; 171: 1194-8. pmid:14767299 PubMed  
  18. McNeill SA, Hargreave TB; Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol 2004; 171: 2316-20. pmid:15126812 PubMed  
  19. Lucas MG, Stephenson TP, Nargund V. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int 2005; 95: 354-7. pmid:15679793 PubMed  
  20. Kumar S, Tiwari DP, Ganesamoni R, Singh SK. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention. Urology 2013; 82: 171-5. pmid:23561712 PubMed  
  21. Alan McNeill S. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol 2004; 45: 45. pmid:15036678 PubMed  
  22. Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int 2009; 83: 44-8. pmid:19641358 PubMed  
  23. Lo KL, Chan MC, Wong A, et al. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia. Int Urol Nephrol 2010; 42: 7-12. pmid:19449121 PubMed  
  24. Ko YH, Kim JW, Kang SG, et al. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome. Neurourol Urodyn 2012; 31: 460-4. pmid:22331691 PubMed  
  25. McNeill A. Prostate size influences the outcome after presenting with acute urinary retention. BJU Int 2005; 95: 907-8. pmid: 15794809 PubMed  
  26. Manikandan R, Srirangam SJ, O'Reilly PH, Collins GN. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey. BJU Int. 2004; 93: 84-8. pmid:14678374 PubMed  
  27. Cullen IM, Dowling CM, Thornhill JA, Grainger R. Emergency management of acute urinary retention: results from an all-Ireland urologist practice survey. Ir J Med Sci 2013; 182: 207-11. pmid:23096424 PubMed  
  28. Desgrandchamps F, De La Taille A, Doublet JD; RetenFrance Study Group. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. BJU Int 2006; 97: 727-33. pmid:16536763 PubMed  
  29. Chen JS, Chang CH, Yang WH, Kao YH. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. BJU Int 2012; 110: E896-901. pmid: 23035623 PubMed  
  30. Muruganandham K, Dubey D, Kapoor R. Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management. Indian J Urol 2007; 23: 347-53. pmid:19718286 PubMed  
  31. Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, et al. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol 2013; 24: 535-42. pmid:23434084 PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Steinar J. Karlsen, tidligere klinikksjef og professor dr. med., Oslo Urologiske Universitetsklinikk, Aker universitetssykehus helseforetak og Universitetet i Oslo
  • Svein Z. Bratland, spesialist i allmennmedisin, Sandviken Legesenter, Bergen, og seniorrådgiver i Statens helsetilsyn, Oslo